Diabetes Mellitus, Type 2

• Early Phase Clinical Unit — Baltimore, Maryland, United States

Not specified

• University of Pittsburgh — Pittsburgh, Pennsylvania, United States

• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. — Neuss, Germany

• GSK Investigational Site — Chula Vista, California, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Baltimore, Maryland, United States
• GSK Investigational Site — San Antonio, Texas, United States

Not specified

• GSK Investigational Site — Harrow, Middlesex, United Kingdom

• GSK Investigational Site — Mesa, Arizona, United States
• GSK Investigational Site — Artesia, California, United States
• GSK Investigational Site — Buena Park, California, United States
• GSK Investigational Site — Fresno, California, United States

• Calgary, Alberta, Canada
• Edmonton, Alberta, Canada
• Coquitlam, British Columbia, Canada
• Surrey, British Columbia, Canada